Key Takeaways
- Fourth straight 9%+ quarter, with a caveat: Organic QoQ growth was 6.8% after absorbing a ~$4 million revenue drop from a restructured IP contract; reported growth remained above 9%.
- Margin defense is the FY23 commitment: EBIT margin held at 14% for the ninth consecutive quarter of improvement, and management is committed to defending that level despite wage hikes and acquisition amortization.
- Acquisition spree pauses for integration: With Data Glove closed and MediaAgility imminent, management declared an absolute focus on integrating six recent deals over the next one to two quarters rather than hunting for new ones.
- IP revenue resets, but margin quality improves: A top-customer IP contract was restructured from revenue-share to T&M, shrinking the top line by 30-35% but lifting its gross margin to company average.
- What to watch next quarter: Whether the MediaAgility close and debt funding complete on schedule, the pace of attrition moderation as fresher batches deploy, and any early signs of synergy revenue from the acquired entities.
Growth Engine & Deal Wins
- Volume-led growth with rate tailwinds: Offshore linear revenue grew 11.5% QoQ on 9.8% volume growth and a 1.5% billing rate increase; onsite linear revenue grew 20.1% QoQ on 17.6% volume growth and a 2.1% rate increase.
- Client mining deepening: The number of >$5M clients rose to 25 and $1-5M clients to 93, indicating improving concentration and wallet share within existing accounts.
- Top customer reset, not a loss: The top-1 customer declined $4.5 million QoQ solely because of the IP-to-T&M restructuring, while the top 2-5, 6-10, and 11-20 categories all showed strong sequential and YoY growth.
- Five-year managed services momentum: Two large deals closed: a PE-backed Cloud and Telecom software firm (with employee re-badging) and a greenfield hybrid multi-cloud build for a PE-led media carve-out in Europe, both five-year engagements.
- BFSI vendor consolidation win: A top-five US bank chose Persistent to modernize payments, wholesale digital experience, and capital markets regulatory reporting, driven by vendor consolidation in the account.
- Healthcare platform engineering: An immune-medicine leader selected Persistent to engineer a next-generation platform on Microsoft Azure for scaling diagnostics and drug discovery; a large biopharma firm chose them for patient relationship management on Salesforce.
Kalra: "I am not overly worried even if the market was to slow down, the capabilities that we have, the kind of deals that we are working on, the kind of customers that we have garnered, and the prospects that we have in the pipeline will still hold."
Margin & Cost Structure
- EBIT margin held at 14% despite headwinds from higher amortization, one-time M&A expenses, and continued talent supply challenges, marking nine consecutive quarters of QoQ improvement.
- EBITDA margin improved to 17.2% from 16.8% QoQ; the gap to EBIT widened because depreciation and amortization rose on new acquisitions.
- BFSI margin dipped because the onsite revenue mix in that vertical increased during the quarter, lowering the overall vertical margin.
- SCI and Shree Partners are margin-neutral: Both acquired entities operate at similar margin levels to the company average, so no dilution is coming from them.
- Amortization headwind quantified: Intangibles amortization from acquisitions is expected to be 70-80 bps for the full year, with the incremental impact including MediaAgility at about 50 bps, moderating as revenues scale.
- Wage hike timing: Annual wage hikes are due 1st July; management is working through moving parts on inflation, market expectations, and the ability to pass some cost to customers, and will update after Q1.
- OCF-to-EBITDA timing noise: Reported Q4 OCF-to-EBITDA was 0.62, depressed by ~₹34 crore of insurance payouts pulled forward from April and ~₹35 crore of collections spilling into April due to paperwork delays; adjusted, Q4 would have been 0.87 and full-year 0.97.
Sapre: "Absolutely, so that is the entire objective for managing the cost."
IP Revenue Reset
- IP-led revenue declined 26% QoQ mainly because one large revenue-share contract with a top customer was restructured to T&M; those revenues now report as services revenue, not IP revenue.
- Contract value shrank, margin quality improved: The restructured contract value reduced to about 30-35% of the original, but is now on T&M with gross margins at company average versus previously deflated margins tied to the product construct.
- IP revenue composition now has three parts: revenue-share (the restructured piece), partner IPs like Outsystems and Saviynt where implementation work drives purchase royalty costs, and the own Accelerite portfolio. The purchase royalty line is not directly linked to the restructured IP revenue.
- IP revenue growth outlook: Expected to grow 10-15%, which may be lower than company-average services growth, reflecting the structural shift in the revenue mix.
Acquisition Integration & Pipeline
- Data Glove closed March 1, 2022: Integration is proceeding along expected lines, with Rajiv Korpal and Rahul Bajaj joining to lead the Cloud Practice on Microsoft.
- MediaAgility closure imminent: Expected to close in the next one to two weeks from the call date (April 28, 2022), with the transaction and debt funding to occur in Q1 FY23.
- SCI and Shree Partners gaining traction: A few large joint opportunities are in the pipeline, with positive developments expected in subsequent quarters.
- Acquisition payout structure: Total gross payout for acquisitions announced in the last two quarters is $220 million, with ~$150 million upfront and the balance as deferred or contingent consideration (earnouts over 2 years, retention over 3 years).
- Debt raised: $25 million for SCI-Fusion 360 and $35 million for Data Glove.
- Integration-first posture: Management stated they have done their share of acquisitions for the time being and are absolutely focused on integrating them over the next one to two quarters to realize synergy revenues; only very opportunistic deals would be considered.
People, Utilization & Attrition
- Attrition moderated slightly: Q4 annualized attrition eased to 26.6% from 26.9% in Q3; efforts on employee engagement, learning, career planning, salary hikes, and ESOPs are working.
- Utilization dipped deliberately: Utilization declined 2.4% QoQ to 80.6% as freshers were added and capacity was created for future ramp-ups.
- Attrition outlook: Trailing 12-month attrition is expected to remain elevated for the time being and decline gradually over FY23; moderation is expected in the second half, though management is not banking on it heavily.
- Fresher intake as a cost lever: Fresher additions from last year and continuing this year will help manage talent pool costs and partially alleviate staffing issues.
- Leadership build-out: Yogesh Patgaonkar joined as Chief People Officer; Sameer Bendre moved from CPO to Chief of Operations; Merlyn Mathew joined as Head for Delivery Excellence and Talent Management; Larry Modder joined as VP for Sourcing Advisory; Phil Fasano (former CIO of AIG and Kaiser Permanente) joined the Persistent Advisor Network.
Demand Environment & Strategy
- No pullback seen: Management sees no pullback in the ISV market or enterprise market as of this point in time, despite the Russia-Ukraine conflict and inflationary pressures.
- ISV exposure is low-risk: Exposure to venture-backed startups as a percentage of revenue is very low; mid-market to larger ISVs are committing for the longer run.
- Technology spend is sticky: Management believes that if macro conditions worsen, technology spend would not be the first to be cut; it is down the line in terms of corporate cost-cutting sequences.
- Hyperscaler ecosystem alignment: Persistent is working with IBM, Microsoft, AWS, Google, and Salesforce to align offerings to their industry-specific cloud roadmaps (Health Cloud, Financial Services Cloud, Sustainability Cloud), positioning beyond lift-and-shift migration toward long-term relevance.
- Eastern Europe conflict: Deal discussions are happening at multiple levels with multiple companies around potential incremental work, but nothing yet at scale to report significantly. Management stated they would not want to gain at the expense of the conflict.
Kalra: "Should there be a scenario going ahead where if, let's say inflation goes much higher, the conflict between Russia Ukraine goes much higher, technology spend will not be the first one to be cut."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBIT margin defense | Defend 14% EBIT margin despite wage hikes and amortization headwinds | FY23 |
| Attrition moderation | Trailing 12-month attrition to decline gradually; moderation expected in H2 | FY23, H2-weighted |
| MediaAgility close | Transaction closure and debt funding | Q1 FY23 |
| Acquisition integration focus | Absolute focus on integrating recent deals; no active M&A hunt | Next 1-2 quarters |
| ESG report release | Comprehensive ESG roadmap and initiatives report | Later part of Q1 FY23 |
| Revenue aspiration | Hit a billion dollars | Next 4-6 quarters |
| IP revenue growth | Grow 10-15%, below company-average services growth | FY23 |
| ETR range | Normal-year ETR of 25.5% to 26% | FY23 |
| Wage hike update | Communicate after completing moving-part analysis | After Q1 FY23 |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| Revenue | $217.32 million, +9.1% QoQ and +42.2% YoY |
| Revenue (INR) | ₹1,637.9 crore, +9.8% QoQ and +47.1% YoY |
| Organic revenue growth (USD) | 6.8% QoQ, +36% YoY; absorbed ~$4M drop from a restructured revenue-share contract |
| EBIT | ₹230 crore, 14.0% margin; +10.4% QoQ and +57.1% YoY |
| EBITDA margin | 17.2%, up from 16.8% in Q3; currency benefit of 30 bps, one-time M&A costs impacted by ~30 bps |
| Profit after tax | ₹201 crore, 12.3% of revenue vs ₹176.4 crore (11.8%) in Q3 |
| Earnings per share (full year FY22) | ₹90.34 per share, vs ₹58.97 in FY21 |
| Total contract value (TCV) | $361 million; new business TCV of $195.1 million |
| Annual contract value (ACV) | $261.9 million; new business ACV of $131 million |
| Full-year FY22 TCV | $1.22 billion; ACV component of $943.3 million |
| Full-year FY22 organic revenue growth | 32.8% |
| Services revenue growth | +14.6% QoQ |
| IP-led revenue | -26% QoQ, due to restructuring of a revenue-share deal into a T&M contract |
| BFSI segment growth | +10% QoQ |
| Technology segment growth | +8.5% QoQ |
| Healthcare segment growth | +9.2% QoQ |
| Utilization | 80.6%, declined 2.4 ppt QoQ as freshers were added and capacity built |
| Attrition (annualized) | 26.6%, moderated from 26.9% in Q3 |
| Total employees | 18,599, net addition of 1,610 including 700 from Data Glove acquisition |
| Cash and investments | ₹1,737.3 crore as at 31 March, vs ₹1,896.4 crore as at 31 December |
| Days sales outstanding | 59 days, vs 58 days in Q3 |
| Dividend per share (full year FY22) | ₹31 per share (final ₹11 + interim ₹20), vs ₹20 in FY21 |